Host Defence (Cationic) Peptides
- 1 January 1999
- journal article
- review article
- Published by Springer Nature in Drugs
- Vol. 57 (4) , 469-473
- https://doi.org/10.2165/00003495-199957040-00002
Abstract
Host defence, cationic antimicrobial peptides are now recognised as an important component, in most species, of the early innate and induced defences against invading microbes. They are small (12 to 35 amino acids), cationic due to the presence of an excess of arginine and lysine over acidic amino acids, and able to fold into a variety of different secondary structures. They have highly desirable properties, such as the ability to kill rapidly a broad spectrum of microorganisms including drug resistant bacteria and often fungi at around the minimal inhibitory concentration, a low level of resistance development in vitro, the ability to protect animals against both topical and systemic infections and the capability to neutralise endotoxin and demonstrated synergy with conventional antibiotics. In addition, given the 20 building blocks (amino acids) for these peptides, even a small peptide offers enormous diversity and potential for design of improved variants. For this reason such peptides have entered clinical trials, largely as agents for topical therapy of polymicrobial infections and are considered to have excellent potential for being a novel antibiotic class.Keywords
This publication has 19 references indexed in Scilit:
- The therapeutic potential of cationic peptidesExpert Opinion on Investigational Drugs, 1998
- Cationic peptides: a new source of antibioticsTrends in Biotechnology, 1998
- Antimicrobial peptides of leukocytesCurrent Opinion in Hematology, 1997
- Gramicidin S is active against both gram‐positive and gram‐negative bacteriaInternational Journal of Peptide and Protein Research, 1996
- Liposomal entrapment of the neutrophil-derived peptide indolicidin endows it with in vivo antifungal activityBiochimica et Biophysica Acta (BBA) - Biomembranes, 1995
- Effect of a Cecropin-like Synthetic Peptide (Shiva-3) on the Sporogonic Development of Plasmodium bergheiExperimental Parasitology, 1995
- Peptide Antibiotics and Their Role in Innate ImmunityAnnual Review of Immunology, 1995
- Recombinant DNA procedures for producing small antimicrobial cationic peptides in bacteriaGene, 1993
- Beta-lactam antibiotics potentiate magainin 2 antimicrobial activity in vitro and in vivoAntimicrobial Agents and Chemotherapy, 1991
- Colistin inhalation therapy in cystic fibrosis patients with chronic Pseudomonas aeruginosa lung infectionJournal of Antimicrobial Chemotherapy, 1987